ToxStrategies’ scientists Jennifer Bare, Mandie Kramer, and Susan Borghoff are excited share their new paper on consumer product exposure to vinyl acetate monomer… read more
It is crucial to complete post-fire assessments before a home is reoccupied. ToxStrategies’ team of industrial hygienists are experienced in evaluating homes affected… read more
Dr. Naomi Sacks, Vice President, BlueRidge Life Sciences’ Pharmaceutical Commercialization division, is attending the annual meeting of ISPOR (The Professional Society for Health Economics… read more
In the United States, the most common childhood central nervous system cancer is pediatric low-grade glioma, but there are no standardized coding definitions… read more
Dr. Stephanie Kennedy is co-author on three posters regarding risk assessment strategies for microplastics and is looking forward to attending scientific platform and… read more
BlueRidge Life Sciences is at the annual meeting of ISPOR (The Professional Society for Health Economics and Outcomes Research), held this year in… read more
BlueRidge Life Sciences Pharmaceutical Commercialization’s Dr. Naomi Sacks’s work published in Obesity Science & Practice on behalf of The Obesity Society was recently… read more
ToxStrategies and EpidStrategies are pleased to announce the promotion of 12 of our scientists, epidemiologists and engineers. We are proud to have them… read more
Dr. William Rish, ToxStrategies’ Principal Engineer, was invited to present to an ad hoc committee assembled by the National Academies of Sciences, Engineering,… read more
ToxStrategies scientists John Rogers, Melissa Heintz, Chad Thompson, and Laurie Haws were recently notified that their paper A putative adverse outcome network for… read more
